In this case-control study a bioactive implant surface was compared with traditional surfaced implants. Primary objectives: Test the implant stability in post-extractive sites, comparing traditional surfaced implants (MultiNeO CS, control group) to bioactive surfaced implants (NINA- MultiNeO NH, treatment group). Primary outcome endpoints were Implant stability, assessed through Implant stability quotient (ISQ) values and Marginal bone loss (MBL)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Marginal bone loss
Timeframe: 6 months after implant placement
Marginal bone loss
Timeframe: 12 months after implant placement
Implant stability
Timeframe: immediately after implant placement
Implant stability
Timeframe: 30 days after implant placement
Implant stability
Timeframe: 45 days after implant placement